Clinical Trial Update: CGM Use in Islet Transplant Recipients [NA]

View source ↗

Summary

Clinical trial update on using continuous glucose monitoring in islet transplant recipients has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Transplantation
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Virginia | Conditions: Islet Transplantation, Type1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2020-08-07